Entities / Company
OrbiMed.
Investment service in New York City, New York
- Reports this week
- 0
- Active events
- 0
- Connections
- 19
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
OrbiMed secured a $400 million senior secured term loan facility, retained TD Cowen as financial advisor, and must file details with the SEC.Some support3 reports
-
J. Mark Joyce completed residency training at Emory University, while Iain D. Dukes serves as an advisor for Dogwood Therapeutics through OrbiMed.Some support1 report
Gone quiet
No new reports in 90+ days-
Renasant Bio announced its launch from Berkeley after securing investments from Atlas Venture and OrbiMed.Some support1 report
-
OrbiMed promoted Mona Ashiya to general partner, noting the company's team is based in New York City.Some support1 report
-
OrbiMed announced it secured a $200 million credit facility and filed a Current Report on Form 8-K with the SEC on July 31, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around OrbiMed this week
News at the entities that move OrbiMed most-
Intellia Therapeutics TransactionalIntellia Therapeutics and BeyondSpring are identified as small-cap healthcare companies.Moves OrbiMed
Connections
The 1 strongest of 19, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Intellia Therapeutics Transactional
A secured a $400 million senior secured term loan facility.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
1 eventJune 2026
3 events- Renasant Bio announced its launch from Berkeley after securing investments from Atlas Venture and OrbiMed.
- OrbiMed promoted Mona Ashiya to general partner, noting the company's team is based in New York City.
- OrbiMed announced it secured a $200 million credit facility and filed a Current Report on Form 8-K with the SEC on July 31, 2025.